|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
KFL011090138 |
003 |
DE-627 |
005 |
20230713210622.0 |
007 |
cr uuu---uuuuu |
008 |
230609s2021 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.2217/nnm-2021-0275
|2 doi
|
035 |
|
|
|a (DE-627)KFL011090138
|
035 |
|
|
|a (KFL)prod_FICIBQ_10.2217/nnm-2021-0275
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
084 |
|
|
|a PHARM
|q DE-84
|2 fid
|
100 |
1 |
|
|a Devkota, Hari P
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases
|c Hari P Devkota, Keshav R Paudel, Niraj K Jha, Piyush K Gupta, Sachin K Singh, Dinesh K Chellappan, Philip M Hansbro, Kamal Dua
|
264 |
|
1 |
|a [Erscheinungsort nicht ermittelbar]
|c 2021
|
300 |
|
|
|a 1 Online-Ressource (4 p)
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
653 |
|
|
|a drug delivery
|
653 |
|
|
|a inflammasomes
|
653 |
|
|
|a pulmonary
|
700 |
1 |
|
|a Paudel, Keshav R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Jha, Niraj K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gupta, Piyush K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Singh, Sachin K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chellappan, Dinesh K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hansbro, Philip M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dua, Kamal
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Nanomedicine
|d London : Future Medicine Ltd, 2006
|h Online-Ressource
|w (DE-627)KFL000006122
|w (DE-600)2254848-8
|w (DE-576)398100551
|x 1748-6963
|7 nnns
|
856 |
4 |
0 |
|u http://pharmazie.proxy.fid-lizenzen.de/fid/future-medicine-ejournals-pharmazie/doi.org/10.2217/nnm-2021-0275
|m X:KFL
|x Resolving-System
|y FID Access
|z lizenzpflichtig
|
912 |
|
|
|a GBV_KFL
|
912 |
|
|
|a FID-PHARM
|
935 |
|
|
|i IMPORT_0628_prod_FICIBQ_03
|
951 |
|
|
|a AR
|